Skip to content

A clinical trial on white discharge in women

A pilot study on gandhaga rasayanam (internal) and thiripala kudineer peechu (external) for treatment of vellai(leucorrhoea).

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011807
Enrollment
10
Registered
2018-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- white discharge pervagina associated with vulval itching

Interventions

Intervention1: gandhaga rasayanam: 5 grams b.i.d 14 days Control Intervention1: nil: nil

Sponsors

National institute of siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Aged between 25-45years (Married Women) 2.Patient willing for basic blood investigations and smear test. 3.Patient willing to sign the informed consent 4.Whitish or yellowish discharge from the vagina 5.Vulval irritation 6.Low backache 7.Lower abdominal pain

Exclusion criteria

Exclusion criteria: 1.Patients taking any other concomitant therapy. 2.Specific vaginitis (Trichomonas,Candidiasis,gardenella,etc) 3.Presence of any pelvic pathology such as Pelvic endometriosis,Adenomyosis 4.IUCD in utero. 5.CA cervix 6.Salphingitis, Oophoritis. 7.Dysfunctional uterine bleeding. Presence of any associated severe systemic illness. 8.Immuno-compromised patients H/O allergy to sulphur containing drugs.

Design outcomes

Primary

MeasureTime frame
It is assessed by the reduction in white discharge per vagina and irritation in the vulva.Timepoint: after 14 days

Secondary

MeasureTime frame
Reduction in other factors related to the disease such as stress and lethargy. Timepoint: after 14 days

Countries

India

Contacts

Public ContactDrTKKalyana sundaram

National institute of siddha

kalyas53@gmail.com9444946270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026